UPDATE – CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
05 févr. 2020 17h21 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- In a release issued earlier today by CURE Pharmaceutical (OTC: CURR), the company is updating this release to include forward looking statements. ...
CURE Pharmaceutical [OTCQB:CURR] Expands to Europe, Signs Licensing Agreement with ReLeaf Europe to Provide Advanced Cannabinoid Delivery
05 févr. 2020 07h15 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Feb. 05, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announced today that it has signed an exclusive licensing...
CURE Pharmaceutical [OTCQB:CURR] to Present at the 12th Annual LD Micro Main Event Investor Conference
05 déc. 2019 07h00 HE
|
Cure Pharmaceutical Holding Corp.
LOS ANGELES, Dec. 05, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it will be presenting at the 12th Annual LD...
CURE Pharmaceutical [OTC: CURR] Names Canopy Rivers’ Chairman, John K. Bell, To Board of Directors
19 nov. 2019 07h00 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that it has named John K. Bell, FCA, FCPA,...
CURE Pharmaceutical [OTCQB:CURR] Takes First Step to Acquire Coeptis Pharmaceuticals and its Combination Drug for Osteoarthritis Pain and Hypertension
14 nov. 2019 07h00 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR) (“CURE”), an innovative drug delivery and development company, today announced that it purchased a $200,000...
CURE Pharmaceutical [OTCQB:CURR] Debuts CUREform Drug Delivery Line Adding Chewables and Emulsions
09 oct. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 09, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, announces the expansion of its oral drug delivery product line...
CURE Pharmaceutical Promotes Dr. Vered Gigi to Chief Scientific Officer
01 oct. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, has appointed Dr. Vered Gigi as its chief scientific officer....
CURE Pharmaceutical [OTCQB: CURR] Takes First Step To Secure Hemp CBD Supply Chain by Partnering with Fytiko Farms
21 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 21, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has signed a deal with Oklahoma-based hemp...
CURE Pharmaceutical Expands Board with Two Women Directors
07 août 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Aug. 07, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced the addition of two directors to its Board,...
CURE Pharmaceutical [OTCQB:CURR] Secures Patent on High Loading of Active Ingredient in Oral Thin Films
24 juil. 2019 07h25 HE
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., July 24, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the allowance of U.S. Application No....